Cullinan Therapeutics Reports Q2 2026 Financial Results

What Happened
Cullinan Therapeutics, Inc. announced its financial results for the three and six months ended June 30, 2026 in a press release dated August 6, 2026. The company filed a Current Report on Form 8-K (Item 2.02) to furnish that press release (Exhibit 99.1). The filing was signed by Mary Kay Fenton, Chief Financial Officer, on August 6, 2026.

Key Details

• Filing date: August 6, 2026 (Form 8-K).
• Period covered: three and six months ended June 30, 2026.
• Press release furnished as Exhibit 99.1 to the 8-K.
• Form signed by Mary Kay Fenton, Chief Financial Officer.

Why It Matters
This 8-K signals that Cullinan has released its latest quarterly results—important for investors tracking earnings, revenue trends, cash runway, and operational progress. The press release furnished with the 8-K is the primary source for the reported figures; investors should read that release and monitor the company’s subsequent SEC filings (e.g., quarterly report on Form 10-Q) for complete financial statements and additional disclosures.